Cargando…
Unmasking of myoclonus by lacosamide in generalized epilepsy
Lacosamide is a new-generation antiseizure medication that is approved for use as an adjunctive treatment and monotherapy in focal epilepsy. Its use in generalized epilepsy, however, has not been adequately evaluated in controlled trials. We report a 67-year-old woman who experienced new-onset myocl...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318289/ https://www.ncbi.nlm.nih.gov/pubmed/28239547 http://dx.doi.org/10.1016/j.ebcr.2016.09.006 |